Skip to main content

Creative Planning

Position in NVS — Novartis AG

CIK 1540235 OVERLAND PARK, KS

Position in NVS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$85,672,398
+$4,896,060 QoQ
Shares Held
546,659
+3.4% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#41
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Creative Planning holds $1,825,978,859 across 16 Drug Manufacturers - General names. NVS ranks #6 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 NVS
Novartis AG
This page
546,659 $85,672,398

All Filings in NVS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $85,672,398 546,659
2026-03-31 $80,776,338 528,814
2025-12-31 $60,519,828 438,963
2025-09-30 $54,350,419 423,818
2025-06-30 $48,193,200 398,258
2025-03-31 $43,141,756 386,991
2024-12-31 $34,424,287 353,759
2024-09-30 $39,676,264 344,951
2024-06-30 $35,287,751 331,465
2024-03-31 $30,625,394 316,607
2023-12-31 $31,319,681 310,188
2023-09-30 $45,590,702 447,582
2023-06-30 $30,399,641 301,255
2023-03-31 $26,359,196 286,513
2022-12-31 $26,230,417 289,136
2022-09-30 $22,890,411 301,150
2022-06-30 $26,441,322 312,804
2022-03-31 $30,051,391 342,466
2021-12-31 $7,546,999 86,281
2021-09-30 $8,597,286 105,127
2021-06-30 $6,578,677 72,103
2021-03-31 $7,372,051 86,243
2020-12-31 $8,443,269 89,413
2020-09-30 $7,547,953 86,798
2020-06-30 $6,547,879 74,970
2020-03-31 $7,403,762 89,797